Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Adult Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02642913
What this trial is testing

Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Memorial Sloan Kettering Cancer Center 28
Not applicableEnded earlyNCT03402607
What this trial is testing

Trial Comparing PLA to HIGRT (PROVE-HCC)

Who this might be right for
Hepatocellular Carcinoma
Duke University 12
Testing effectiveness (Phase 2)WithdrawnNCT02946138
What this trial is testing

Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Proton and Heavy Ion Center
Testing effectiveness (Phase 2)Study completedNCT00009893
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 42
Testing effectiveness (Phase 2)WithdrawnNCT04526080
What this trial is testing

Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT03867370
What this trial is testing

Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 40
Early research (Phase 1)Ended earlyNCT04502082
What this trial is testing

Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more
Eureka Therapeutics Inc. 8
Testing effectiveness (Phase 2)UnknownNCT00162669
What this trial is testing

Bevacizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 50
Testing effectiveness (Phase 2)Study completedNCT05101629
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 32
Testing effectiveness (Phase 2)Ended earlyNCT00971126
What this trial is testing

Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Health Research Institutes, Taiwan 3
Testing effectiveness (Phase 2)Study completedNCT00554372
What this trial is testing

Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Jennerex Biotherapeutics 30
Testing effectiveness (Phase 2)Study completedNCT00056992
What this trial is testing

Testing of ADI-PEG in Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
FDA Office of Orphan Products Development 34
Early research (Phase 1)Study completedNCT01497444
What this trial is testing

Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney CancerLiver Cancer
Alliance for Clinical Trials in Oncology 24
Testing effectiveness (Phase 2)Study completedNCT05003700
What this trial is testing

Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT07138885
What this trial is testing

A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)Second Line Treatment
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Study completedNCT00003923
What this trial is testing

Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more
Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT01687673
What this trial is testing

Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of California, San Francisco 29
Large-scale testing (Phase 3)Temporarily pausedNCT04268888
What this trial is testing

Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma
The Clatterbridge Cancer Centre NHS Foundation Trust 522
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06984718
What this trial is testing

A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC

Who this might be right for
HCCHepatocellular Carcinoma
Akeso 120
Next Page